IQVIA Holdings | IQV - Debt


IQVIA Holdings reported $16.24B in Debt for its fiscal quarter ending in June of 2026.





Debt Change Date
Accenture USD 5.14B 2.12M Mar/2026
Agilent USD 3.36B 1000K Mar/2026
Bruker USD 1.82B 153.5M Jun/2026
Cardinal Health USD 8.89B 30M Jun/2026
Celltrion KRW 160.58B 733.3M Mar/2026
Charles River Laboratories USD 3.06B 485.84M Mar/2026
Cigna USD 30.9B 563M Mar/2026
Cognizant Technology Solutions USD 1.09B 516M Mar/2026
Cspc Pharmaceutical CNY 641.11M 146.11M Dec/2025
CVS Health USD 61.41B 16.94B Jun/2026
Danaher USD 26.56B 8.07B Jun/2026
Dentsply International USD 2.33B 137M Mar/2026
Deva Holding AS TRY 5.3B 871.93M Sep/2023
Dianthus Therapeutics USD 1.36M 79K Mar/2026
Divis Laboratories Ltd INR 70M 30M Mar/2026
Elevance Health USD 31.04B 798M Jun/2026
Humana USD 14.25B 254M Jun/2026
IBM USD 69.8B 5.2B Mar/2026
Illumina USD 2.54B 9M Mar/2026
Infosys INR 3.33B 220.1M Mar/2026
Kangmei Pharma CNY 173.71M 42.08M Mar/2026
Knight Therapeutics CAD 77.91M 28.33M Dec/2025
Laboratorios Farma EUR 129.3M 14.89M Jun/2025
Laboratory Of America USD 7.24B 714.6M Mar/2026
Malin Corporation EUR 100K 0 Dec/2023
McKesson USD 8.61B 10M Mar/2026
Mettler Toledo International USD 2.23B 76.47M Mar/2026
Organigram Holdings CAD 8.2M 554K Mar/2026
Ovoca Bio EUR 0 0 Jun/2021
Pharma Mar EUR 45.84M 1.7M Jun/2026
Publicis EUR 5.66B 202M Dec/2025
Qiagen NV USD 1.65B 165.82M Mar/2026
Quest Diagnostics USD 6.41B 179M Mar/2026
Revvity USD 3.35B 48.03M Mar/2026
Sartorius EUR 4.05B 248.8M Jun/2026
Sino Biopharmaceutical CNY 9.71B 33.98M Dec/2024
Thermo Fisher Scientific USD 43.16B 3.78B Mar/2026
Tilray USD 640.95M 35.17M Jun/2022
UnitedHealth USD 73.33B 4.59B Jun/2026
Veeva Systems USD 103.07M 7.21M Mar/2026
Veradigm USD 200.33M 431K Sep/2022
Waters USD 5.57B 4.08B Mar/2026
Zealand Pharma A/S 414M 8.23M Mar/2026
Zz Pientze Pharmaceu CNY 1.07B 2.82M Mar/2026